# Cytek Biosciences, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:416d72fb-be74-43a6-9771-3f393aea68af | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/cytek-biosciences-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 31 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T04:46:18.168414+00:00 | | Last reviewed | 2026-10-16T04:46:18.168414+00:00 | ## Identity - Legal name: Cytek Biosciences, Inc. - Display name: Cytek Biosciences, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T08:07:24.119941+00:00 | | Completeness | 0.409 | | Record Quality | 0.823 | | Directors | 10 | | Committees | 4 | | Governance events | 5 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Deborah Neff: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. Committees: Audit Committee (member); Nominating and Corporate Governance Committee (member). claim_id=alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:5 - Jack Ball: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. Committees: Audit Committee (member); Compensation Committee (chair). claim_id=alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:7 - Michael Holder: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. Committees: Audit Committee (chair); Compensation Committee (member). claim_id=alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:8 - Richard Chin: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. Committees: Nominating and Corporate Governance Committee (member). claim_id=alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:10 - Vera Imper: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. Committees: Compensation Committee (member); Nominating and Corporate Governance Committee (chair). claim_id=alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:12 - Glenn P. Muir: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:6 - Ming Yan, Ph.D.: Chief Technology Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:9 - Richard Chin, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:11 - Vera Imper, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:13 - Wenbin Jiang, Ph.D.: Chief Executive Officer, President and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: President and Director (member). claim_id=alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:14 ## Committees - Audit Committee (audit). Chair: Michael Holder. Members: Michael Holder (chair, current); Deborah Neff (member, current); Jack Ball (member, current). committee_id=alpha:committee:cytek-biosciences-inc:audit-committee - Compensation Committee (compensation). Chair: Jack Ball. Members: Jack Ball (chair, current); Michael Holder (member, current); Vera Imper (member, current). committee_id=alpha:committee:cytek-biosciences-inc:compensation-committee - Nominating and Corporate Governance Committee (nominating_governance). Chair: Vera Imper. Members: Vera Imper (chair, current); Deborah Neff (member, current); Richard Chin (member, current). committee_id=alpha:committee:cytek-biosciences-inc:nominating-and-corporate-governance-committee - President and Director (other). Chair: NOT_PUBLISHED. Members: Wenbin Jiang, Ph.D. (member, unknown). committee_id=alpha:committee:cytek-biosciences-inc:president-and-director ## Executive leadership - Ming Yan, Ph.D.: Chief Technology Officer [CTO]. Status: unknown. claim_id=alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:15 - Philippe Busque, Ph.D.: Senior Vice President, Global Sales and Services. Status: unknown. claim_id=alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:16 - Valerie Barnett: Chief Legal Officer and Corporate Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:17 - Wenbin Jiang, Ph.D.: Chief Executive Officer and President [CEO]. Status: unknown. claim_id=alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:18 - William McCombe: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:19 ## Governance events - DIRECTOR_APPOINTED: Deborah Neff seat on Cytek Biosciences, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:15h1ljr1jh1ect - DIRECTOR_APPOINTED: Richard Chin seat on Cytek Biosciences, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:1bfgn5z182l9fl - DIRECTOR_APPOINTED: Michael Holder seat on Cytek Biosciences, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:al3i25118aqe5 - DIRECTOR_APPOINTED: Vera Imper seat on Cytek Biosciences, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:1g72mg51d4bhtj - DIRECTOR_APPOINTED: Jack Ball seat on Cytek Biosciences, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T04:46:18.168414+00:00. event_id=alpha:event:transition:z9zfxh1ad81f1 ## Scoped resources - `alpha://company/cytek-biosciences-inc` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record - `alpha://company/cytek-biosciences-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=identity - `alpha://company/cytek-biosciences-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=corporate-structure - `alpha://company/cytek-biosciences-inc/board` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=board - `alpha://company/cytek-biosciences-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=committees - `alpha://company/cytek-biosciences-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=leadership - `alpha://company/cytek-biosciences-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=ownership - `alpha://company/cytek-biosciences-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=financials - `alpha://company/cytek-biosciences-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=capital-structure - `alpha://company/cytek-biosciences-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=compensation - `alpha://company/cytek-biosciences-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=governance - `alpha://company/cytek-biosciences-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=shareholder-governance - `alpha://company/cytek-biosciences-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=audit - `alpha://company/cytek-biosciences-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=legal - `alpha://company/cytek-biosciences-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=risk - `alpha://company/cytek-biosciences-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=cyber - `alpha://company/cytek-biosciences-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=ai-governance - `alpha://company/cytek-biosciences-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=agents - `alpha://company/cytek-biosciences-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=ecosystem - `alpha://company/cytek-biosciences-inc/events` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=events - `alpha://company/cytek-biosciences-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=relationships - `alpha://company/cytek-biosciences-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=assessments - `alpha://company/cytek-biosciences-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:michael-holder-ctkb","name":"Michael Holder"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:deborah-neff-ctkb","name":"Deborah Neff"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jack-ball-ctkb","name":"Jack Ball"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:jack-ball-ctkb","name":"Jack Ball"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:michael-holder-ctkb","name":"Michael Holder"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:vera-imper-ctkb","name":"Vera Imper"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:vera-imper-ctkb","name":"Vera Imper"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:deborah-neff-ctkb","name":"Deborah Neff"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:richard-chin-ctkb","name":"Richard Chin"},"source_id":"governance_people_committees"}` ## Leadership - Deborah Neff: Director. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:5. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e38b57e43850c68becb938502375a29b74686caf54fb8934ff6b3ca83afd93f2. - Glenn P. Muir: Director. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cbc15f688d10a3024165ccaefa69f60dbfde61b42e48da71de0ae92321ff89f6. - Jack Ball: Director. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:7. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e38b57e43850c68becb938502375a29b74686caf54fb8934ff6b3ca83afd93f2. - Michael Holder: Director. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e38b57e43850c68becb938502375a29b74686caf54fb8934ff6b3ca83afd93f2. - Ming Yan, Ph.D.: Chief Technology Officer and Director. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cbc15f688d10a3024165ccaefa69f60dbfde61b42e48da71de0ae92321ff89f6. - Richard Chin: Director. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:10. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e38b57e43850c68becb938502375a29b74686caf54fb8934ff6b3ca83afd93f2. - Richard Chin, M.D.: Director. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cbc15f688d10a3024165ccaefa69f60dbfde61b42e48da71de0ae92321ff89f6. - Vera Imper: Director. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:12. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e38b57e43850c68becb938502375a29b74686caf54fb8934ff6b3ca83afd93f2. - Vera Imper, Ph.D.: Director. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cbc15f688d10a3024165ccaefa69f60dbfde61b42e48da71de0ae92321ff89f6. - Wenbin Jiang, Ph.D.: Chief Executive Officer, President and Director. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cbc15f688d10a3024165ccaefa69f60dbfde61b42e48da71de0ae92321ff89f6. - Ming Yan, Ph.D.: Chief Technology Officer. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cbc15f688d10a3024165ccaefa69f60dbfde61b42e48da71de0ae92321ff89f6. - Philippe Busque, Ph.D.: Senior Vice President, Global Sales and Services. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cbc15f688d10a3024165ccaefa69f60dbfde61b42e48da71de0ae92321ff89f6. - Valerie Barnett: Chief Legal Officer and Corporate Secretary. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cbc15f688d10a3024165ccaefa69f60dbfde61b42e48da71de0ae92321ff89f6. - Wenbin Jiang, Ph.D.: Chief Executive Officer and President. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cbc15f688d10a3024165ccaefa69f60dbfde61b42e48da71de0ae92321ff89f6. - William McCombe: Chief Financial Officer. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cbc15f688d10a3024165ccaefa69f60dbfde61b42e48da71de0ae92321ff89f6. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit Committee: Chair Michael Holder; Members Michael Holder (Chair); Deborah Neff; Jack Ball. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:adc54343c4dac970704716ed5adde72e07b1d0d8afdfe5dec8379fca6bd87795. - Compensation Committee: Chair Jack Ball; Members Jack Ball (Chair); Michael Holder; Vera Imper. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:adc54343c4dac970704716ed5adde72e07b1d0d8afdfe5dec8379fca6bd87795. - Nominating and Corporate Governance Committee: Chair Vera Imper; Members Vera Imper (Chair); Deborah Neff; Richard Chin. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_record:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:adc54343c4dac970704716ed5adde72e07b1d0d8afdfe5dec8379fca6bd87795. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Cytek Biosciences, Inc.. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3ac5997fc43c11a1b8b93c8c9ed8019f6483d7b382503d7d0d867a70d6bf0264. ## Entity Status - Public listing published. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3ac5997fc43c11a1b8b93c8c9ed8019f6483d7b382503d7d0d867a70d6bf0264. ## Published Fact - US. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3ac5997fc43c11a1b8b93c8c9ed8019f6483d7b382503d7d0d867a70d6bf0264. ## Committee Appointment - Michael Holder: chair, Audit Committee. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:adc54343c4dac970704716ed5adde72e07b1d0d8afdfe5dec8379fca6bd87795. - Deborah Neff: member, Audit Committee. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:adc54343c4dac970704716ed5adde72e07b1d0d8afdfe5dec8379fca6bd87795. - Jack Ball: member, Audit Committee. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:adc54343c4dac970704716ed5adde72e07b1d0d8afdfe5dec8379fca6bd87795. - Jack Ball: chair, Compensation Committee. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:adc54343c4dac970704716ed5adde72e07b1d0d8afdfe5dec8379fca6bd87795. - Michael Holder: member, Compensation Committee. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:adc54343c4dac970704716ed5adde72e07b1d0d8afdfe5dec8379fca6bd87795. - Vera Imper: member, Compensation Committee. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:adc54343c4dac970704716ed5adde72e07b1d0d8afdfe5dec8379fca6bd87795. - Vera Imper: chair, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:adc54343c4dac970704716ed5adde72e07b1d0d8afdfe5dec8379fca6bd87795. - Deborah Neff: member, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:adc54343c4dac970704716ed5adde72e07b1d0d8afdfe5dec8379fca6bd87795. - Richard Chin: member, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:adc54343c4dac970704716ed5adde72e07b1d0d8afdfe5dec8379fca6bd87795. ## Security Listing - CTKB (NASDAQ). Claim: alpha:claim:company:416d72fb-be74-43a6-9771-3f393aea68af:security_listing:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3ac5997fc43c11a1b8b93c8c9ed8019f6483d7b382503d7d0d867a70d6bf0264. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:3ac5997fc43c11a1b8b93c8c9ed8019f6483d7b382503d7d0d867a70d6bf0264: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/cytek-biosciences-inc). - alpha:projection-evidence:document:e38b57e43850c68becb938502375a29b74686caf54fb8934ff6b3ca83afd93f2: [DEF 14A ny20066946x1_def14a.htm](https://www.sec.gov/Archives/edgar/data/1831915/000114036126017479/ny20066946x1_def14a.htm). - alpha:projection-evidence:document:cbc15f688d10a3024165ccaefa69f60dbfde61b42e48da71de0ae92321ff89f6: [SEC DEF 14A 0001140361-26-017479](https://www.sec.gov/Archives/edgar/data/1831915/000114036126017479/ny20066946x1_def14a.htm). - alpha:projection-evidence:adc54343c4dac970704716ed5adde72e07b1d0d8afdfe5dec8379fca6bd87795: [Audit Committee](https://www.sec.gov/Archives/edgar/data/1831915/000114036126017479/ny20066946x1_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/cytek-biosciences-inc) - [Public Markdown](https://registry.alpha.ac/companies/cytek-biosciences-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/cytek-biosciences-inc?format=jsonld) - MCP resource: `alpha://companies/cytek-biosciences-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T08:07:23.893258+00:00; recorded 2026-10-16T08:07:23.893258+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.